These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 37110574)

  • 1. A Review of the Development of Multitarget Molecules against HIV-TB Coinfection Pathogens.
    Leite DI; de Castro Bazan Moura S; da Conceição Avelino Dias M; Costa CCP; Machado GP; Pimentel LCF; Branco FSC; Moreira R; Bastos MM; Boechat N
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New azaaurone derivatives as potential multitarget agents in HIV-TB coinfection.
    Leite DI; Campaniço A; Costa PAG; Correa IA; da Costa LJ; Bastos MM; Moreira R; Lopes F; Jordaan A; Warner DF; Boechat N
    Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300560. PubMed ID: 38032154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis and HIV Coinfection.
    Bruchfeld J; Correia-Neves M; Källenius G
    Cold Spring Harb Perspect Med; 2015 Feb; 5(7):a017871. PubMed ID: 25722472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis: burning issues: multidrug resistance and HIV-coinfection.
    Janbaz KH; Qadir MI; Ahmad B; Sarwar A; Yaqoob N; Masood MI
    Crit Rev Microbiol; 2012 Nov; 38(4):267-75. PubMed ID: 22421086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tuberculosis and HIV co-infection: a therapeutic challenge].
    Charbonnier F; Calmy A; Janssens JP
    Rev Med Suisse; 2011 Nov; 7(318):2295-6, 2298-300. PubMed ID: 22400365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone as a novel inhibitor of methionine aminopeptidases from Mycobacterium tuberculosis.
    John SF; Aniemeke E; Ha NP; Chong CR; Gu P; Zhou J; Zhang Y; Graviss EA; Liu JO; Olaleye OA
    Tuberculosis (Edinb); 2016 Dec; 101S():S73-S77. PubMed ID: 27856197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between antiretroviral therapy and antitubercular drug resistance in TB treatment outcome among Kazakh TB/HIV co-infected patients.
    Mishkin K; Alaei K; Alikeyeva E; Paynter C; Aringazina A; Alaei A
    J Glob Antimicrob Resist; 2018 Sep; 14():104-108. PubMed ID: 29496619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
    Shoko C; Chikobvu D; Bessong PO
    S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment of hepatotoxicity among tuberculosis and human immunodeficiency virus/AIDS-coinfected patients under tuberculosis treatment.
    Ngouleun W; Biapa Nya PC; Pieme AC; Telefo PB
    Int J Mycobacteriol; 2016 Dec; 5(4):482-488. PubMed ID: 27931691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune reconstitution inflammatory syndrome presenting as chylothorax in a patient with HIV and Mycobacterium tuberculosis coinfection: a case report.
    Lin JN; Lai CH; Chen YH; Chang LL; Lee SS; Lin HH
    BMC Infect Dis; 2010 Nov; 10():321. PubMed ID: 21059235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium tuberculosis and human immunodeficiency virus coinfection in a tertiary care hospital in Midwestern Brazil.
    Lins TB; Soares Ede M; dos Santos FM; Mandacaru PM; Pina T; de Araújo Filho JA
    Infez Med; 2012 Jun; 20(2):108-16. PubMed ID: 22767310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges of TB and HIV co-treatment: updates and insights.
    Tornheim JA; Dooley KE
    Curr Opin HIV AIDS; 2018 Nov; 13(6):486-491. PubMed ID: 30080683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of antiretroviral and tuberculosis therapies on CD4
    Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D
    Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis and HIV coinfection.
    Gray JM; Cohn DL
    Semin Respir Crit Care Med; 2013 Feb; 34(1):32-43. PubMed ID: 23460004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling HIV/AIDS and tuberculosis coinfection.
    Bhunu CP; Garira W; Mukandavire Z
    Bull Math Biol; 2009 Oct; 71(7):1745-80. PubMed ID: 19475456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New management approaches to tuberculosis in people living with HIV.
    Mhango DV; Mzinza DT; Jambo KC; Mwandumba HC
    Curr Opin Infect Dis; 2021 Feb; 34(1):25-33. PubMed ID: 33315751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales.
    Kipp AM; Pungrassami P; Stewart PW; Chongsuvivatwong V; Strauss RP; Van Rie A
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1540-5, i. PubMed ID: 22008770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Complexities Among Patients with Tuberculosis in a High HIV Prevalence Cohort in the United States.
    Bizune DJ; Kempker RR; Kagei M; Yamin A; Mohamed O; Holland DP; Oladele A; Wang YF; Rebolledo PA; Blumberg HM; Ray SM; Schechter MC
    AIDS Res Hum Retroviruses; 2018 Dec; 34(12):1050-1057. PubMed ID: 30105915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current characteristics of tuberculosis and human immunodeficiency virus co-infection in a cohort of hospitalized patients in Medellín, Colombia.
    Ruiz L; Maya MA; Rueda ZV; López L; Vélez LA
    Biomedica; 2018 Aug; 38(0):59-67. PubMed ID: 30184364
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.